Provider QP8-26 Commercial Pharmacy Benefit Exclusion for Exdensur, Ustekinumab-aauz, Vancomycin hcl Read More Program effective Date: Feb 11, 2026
Provider QP7-26 Commercial Pharmacy Benefit Exclusion for Select Medications Read More Program effective Date: Feb 11, 2026
Provider QP6-26 Commercial and MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective April 1, 2026 Read More Program effective Date: Feb 11, 2026
Provider QP5-26 MHCP Pharmacy Benefit Exclusion for Exdensur and Rybrevant Faspro™ Read More Program effective Date: Feb 11, 2026